|Day Low/High||48.76 / 49.14|
|52 Wk Low/High||41.93 / 50.84|
The secret to using emotions to trade better is to analyze them in an objective manner.
Starbucks' steady growth in China could slip again.
What you need to know ahead of the announcement of Starbucks' fourth-quarter results.
My target price and panic points have changed, and I am watching for a chance to add or shave some off, depending on which direction the stock takes.
Cannabis and tobacco are hard to equate, which Barclays' primer on the Cannabis industry misses.
On Wednesday, Canada becomes the first major economy to legalize the recreational use of cannabis.
Several top financial newsletter advisors offer their favorite restaurant names for investors to chew on.
The time to scoop up Altria is now, not when some type of official announcement is made.
Market experts are abuzz over Constellation's potential new inroads into the cannabis market.
There are several avenues to invest in the potential cannabis boom -- recreational plays; medical plays; and companies that have a lot to gain from the industry but aren't reliant upon it for success.
Nooyi's reign may have been viewed through rose colored glasses.
Pepsi's CFO may be tenative, but experts say that cannabis is in Pepsi's future whether they like it or not.
Before your day is over, as Doug would say, be sure to run, not walk over to the Stock of the Day coverage on PepsiCo on Real Money. There is some great stuff being said by Kevin Curran, Rev Shark, and Bruce Kamich. Tucked inside the PepsiCo confer...
The newly minted CEO certainly has challenges ahead, but he has catalysts too.
Patience and good timing are among the keys to their success.
The only other option is 'to fearfully wait' for the legal-weed industry to expand.
Covered calls may be the best bet -- or wait for a dip.
Expect more companies to join Coca-Cola, Molson Coors and Constellation Brands in checking out the market.
A tie-up between the two could mark the first major U.S. firm to establish a line of CBD drinks.
The latest reports about Coke looking into cannabis confirms a broader industry trend.
Not every cannabis stock was strong on Wednesday. One significant Canadian name sure was though.
Moody's and Zacks aren't seeing the potential for CBD drinks or even THC drinks.
Starbucks has been a long time short of mine - its been on my Best Ideas List (short) for several years. The stock was placed on the list in early 2016 at $60.60. Responding to my expectation of saturation in its domestic market (slowing comps rela...
Shares hit the snooze button on Friday's deal.
The Coke Deal's reach extends beyond the two parties involved.
Coke's acquisition of Costa is a strategic move to expand into coffee -- and China.
Despite $5.1 billion deal for Costa, I'm not slurping any KO up.